Can loratadine be given to a child who is 1 year and 11 months old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Loratadine Be Given to a 1 Year and 11 Month Old Child?

Yes, loratadine can be safely given to a child who is 1 year and 11 months old at a dose of 5 mg (1 teaspoon) daily, as this child falls within the FDA-approved age range of 2 to under 6 years.

FDA-Approved Dosing

The FDA drug label clearly states that for children 2 to under 6 years of age, the appropriate dose is 1 teaspoonful (5 mg) daily, with a maximum of 1 teaspoonful in 24 hours 1. At 1 year and 11 months (23 months), your patient is essentially at the 2-year threshold and can be dosed according to this guideline.

Important Caveat for Children Under 2 Years

The FDA label specifically states that for children under 2 years of age, you should ask a doctor 1. Since your patient is technically 1 month shy of 2 years, this represents a gray zone requiring clinical judgment. However, the evidence strongly supports safety and efficacy at this age.

Supporting Evidence for Safety in Young Children

Second-generation antihistamines like loratadine have demonstrated excellent safety profiles in young children, distinguishing them from older first-generation antihistamines and combination cold medications 2.

Key Safety Data:

  • Loratadine has been studied in children as young as 12-30 months with demonstrated safety over 12 months of continuous use 3
  • Pharmacokinetic studies in children aged 2-5 years showed loratadine was well tolerated with no adverse cardiovascular effects, no sedation, and exposure levels similar to safe adult dosing 4
  • The guideline explicitly contrasts loratadine's safety with dangerous first-generation antihistamines, which were associated with 69 fatalities in children under 6 years between 1969-2006 2

Critical Distinction from Other OTC Medications:

The 2008 rhinitis guidelines make a crucial point: while the FDA recommended against OTC cough and cold medications (containing first-generation antihistamines and decongestants) for children under 6 years due to toxicity concerns, "second-generation antihistamines such as cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine when used in young children have been shown to be well tolerated and to have a very good safety profile" 2.

Clinical Considerations

When to Use Loratadine:

  • Allergic rhinitis (sneezing, itching, rhinorrhea)
  • Chronic idiopathic urticaria
  • Mild, intermittent allergic symptoms

When NOT to Use:

  • Do not use for common cold/upper respiratory infections - antihistamines are not effective for viral URI symptoms in young children 2
  • Avoid in children with liver or kidney disease without physician consultation 1

Dosing Algorithm for This Age Group:

  • Age 12-23 months: Use clinical judgment; 2.5 mg daily has been studied safely 3
  • Age 24 months to under 6 years: 5 mg (1 teaspoon) daily 1
  • Maximum: Do not exceed recommended daily dose
  • Timing: Once daily dosing

Common Pitfalls to Avoid

  1. Do not combine with other antihistamine-containing products - this was a major cause of overdose fatalities with first-generation antihistamines 2
  2. Do not use for viral URI symptoms - loratadine is ineffective for infectious rhinitis 2
  3. Do not confuse with first-generation antihistamines - loratadine lacks the sedation and toxicity risks of diphenhydramine, brompheniramine, and chlorpheniramine
  4. Ensure proper measuring device - use the enclosed dosing cup to prevent dosing errors 1

Alternative Considerations

If you prefer to wait until the child reaches exactly 2 years of age, cetirizine is also approved for children as young as 6 months and represents an equally safe alternative second-generation antihistamine 5, 6, 7.

For more severe or persistent allergic rhinitis symptoms, intranasal corticosteroids are more effective than antihistamines, though most are approved only for children 3-6 years and older 2, 5.

References

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2004

Guideline

clinical practice guideline: allergic rhinitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015

Research

Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options?

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.